Clinical Dementia Rating Medical Record

Clinical Dementia Rating (CDR) Face-to-face Interview With the Patient Clinical Trial

— CLIMER  

Official title:

Reliability of the Clinical Dementia Rating Scale From the Medical Record in Comparison With the Reference Method.

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04763941
• Other study ID #: 69HCL20_0508
• Status: Recruiting
• Start date: January 1, 2020
• Est. completion date: December 31, 2022

Study information

• Verified date: January 2022
• Source: Hospices Civils de Lyon
• Contact: Anthony Bathsavanis, Psy D
• Phone: 4 72 432 206
• Email: anthony.bathsavanis[@]chu-lyon.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The assessment of severity of the cognitive and functional impairment is essential in the follow-up of patients with neurocognitive disorders and in the assessment of the effectiveness of therapeutics. However, the systematic assessment of the Clinical Dementia Rating (CDR) scale is limited due to the time required to complete it (approximately 45 min to 1 hour). Insofar as studies have shown correspondences between the CDR and scales measuring cognitive and neuropsychological performance, and as part of memory consultations, several functional and neuropsychological scales are systematically administered, we wish to conduct a study validating the feasibility of the CDR based on information already available in the patient's file compared to the evaluation of the CDR by the usual method (face-to-face interview in consultation).

This study should highlight the feasibility of scoring the CDR-SB from the files of patients in memory consultation, first in terms of reliability of the scores obtained compared to the standard evaluation, and on the other hand in terms of organization and duration of administration.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 144
• Est. completion date: December 31, 2022
• Est. primary completion date: October 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• Patient who has CDR assessment in face-to-face interview during the memory consultation,

• Patient with an isolated cognitive complaint or a neurocognitive disorder

• Patient included in the MEMORA cohort

Exclusion Criteria:

• Patient or caregiver who does not wish their data to be used for research purposes within the framework of the MEMORA cohort.

Related Conditions & MeSH terms

• Alzheimer Disease
• Clinical Dementia Rating (CDR) Face-to-face Interview With the Patient
• Clinical Dementia Rating (CDR) From the Analysis of Medical Record
• Dementia

Intervention

Diagnostic Test:
• CDR assessment face-to-face
The assessment of the CDR is administered once by a psychologist with the patient and his caregiver.

Locations

Country	Name	City	State
France	Hôpital Des Charpennes	Villeurbanne

Sponsors (1)

Lead Sponsor	Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	CDR Sum of boxes (CDR-SB) score out of 18	The CDR-SB score is obtained in normal condition and on file for the same patients. The CDR-SB score makes it possible to distinguish the following classes: 0 (normal), 0.5-4 (questionable cognitive impairment), 0.5-2.5 (questionable impairment), 3-4 (very mild major TNC or very mild dementia), 4.5- 9 (mild or mild dementia), 9.5-15.5 (moderate dementia), 16-18 (severe dementia).; The patient's aptitudes are assessed in 6 different areas: 3 cognitive skills: memory, orientation and judgment, 3 acts of everyday living: participation in collective life, home occupations and hobbies, personal care.	The CDR-SB score is collected at the baseline.